This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07042/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07042/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07042/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07042/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07042
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB07042 n8:DB07042
dcterms:title
7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide
adms:identifier
n10:25023706 n11:99443513 n12:DB07042 n13:3BA
n3:IUPAC-Name
n4:271B43F6-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B43FC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B43FB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B43F8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B43F9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B43FA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B43F4-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B43F2-363D-11E5-9242-09173F13E4C5 n4:271B43F5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B43F3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4402-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4403-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B43FD-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B43FE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4400-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B43FF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4401-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4408-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B440A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B440B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4407-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4406-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4409-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B43F7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4404-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4405-363D-11E5-9242-09173F13E4C5